Lipocine (LPCN) Announces Favorable Regulatory Pathway on Oral LPCN 1154
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| LIPOCINE (NASDAQ: LPCN) | Delayed: 1.44 -0.02 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.46 | 52 Week High | $14.80 | |||
| Open | $1.42 | 52 Week Low | $2.51 | |||
| Day High | $1.48 | P/E | N/A | |||
| Day Low | $1.41 | EPS | $-0.69 | |||
| Volume | 218,656 | |||||
